ATOSSA THERAPEUTICS, INC. Impairment of Long-Lived Assets Held-for-use
ATOSSA THERAPEUTICS, INC. (ATOS) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2022-02-28
- ATOSSA THERAPEUTICS, INC. impairment of long-lived assets held-for-use for the quarter ending 2014-03-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2021 was $0.00.
- ATOSSA THERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2020 was $0.00.
- ATOSSA THERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2019 was $0.00.
- ATOSSA THERAPEUTICS, INC. impairment of long-lived assets held-for-use for fiscal 2018 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 12 month | Impairment of Long-Lived Assets Held-for-use 12 month as first filed | Impairment of Long-Lived Assets Held-for-use 56 month | Impairment of Long-Lived Assets Held-for-use 59 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | ||||
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 | ||||
| 2019-12-31 | $0.00 10-K · filed 2020-03-26 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-26 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-28 | $461.71K 10-K · filed 2018-03-08 | |||
| 2016-12-31 | $718.97K 10-K · filed 2018-03-08 | ||||
| 2015-12-31 | $0.00 10-K · filed 2016-03-30 | ||||
| 2014-12-31 | $2.35M 10-K · filed 2016-03-30 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $158.29K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $158.29K 10-K · filed 2015-03-30 | $158.29K 10-K · filed 2014-03-27 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |